Inside the Gene Therapy for Coronary Artery Disease with XyloCor Therapeutics' Albert Gianchetti

Cell & Gene: The Podcast

English - November 11, 2021 09:00 - 15 minutes - 10.6 MB - ★★★★★ - 35 ratings
Life Sciences Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Advancing Patient Engagement with Novartis Gene Therapies' Dr. Amy Nicole Nayar

Next Episode: Understanding CAR-M Technology with Carisma Therapeutics' Dr. Debora Barton

We love to hear from our listeners. Send us a message.

XyloCor Therapeutics' EXACT clinical trial is a Phase 1/2 multicenter, open-label, single arm, dose escalation trial for coronary artery disease — the most common type of heart disease — with gene therapy at its center.